Tranexamic Acid Injection BP (100mg/ml)
-
Product is not available
Country Of Origin : India
Tranexamic Acid Injection BP
Tranexamic Acid Injection BP is a biocompatible injectable formulation designed to inhibit fibrinolysis and stabilize clot formation. The 100mg/ml concentration ensures precise dosing for clinical hemostatic interventions.
This standardized dosage supports rapid hemostatic control, making it suitable for surgical, trauma, and institutional applications.
Key Features:
- High solubility and stability in isotonic solution
- Optimized for rapid systemic fibrinolytic inhibition
- Minimizes injection site irritation due to controlled pH
- Single-use vial ensures dosage accuracy
Attributes:
- 100mg/ml per vial for predictable therapeutic effect
- Injectable formulation with uniform flow
- Suitable for bulk hospital and institutional procurement
Composition and Formulation Details
The formulation contains pharmaceutically pure tranexamic acid dissolved in sterile isotonic medium with stabilizers to maintain chemical integrity and solubility. This ensures accurate dosing and long-term stability for clinical use.
Functional Characteristics and Performance
The low-viscosity injectable provides smooth systemic administration, rapid hemostatic action, and predictable pharmacokinetics. Shelf-stable under controlled conditions, it allows for repeatable therapeutic performance.
Application and Industry Relevance
Used widely in hospitals, surgical centers, and trauma care, this injection is suitable for bulk sourcing, OEM supply, and export-ready pharmaceutical operations. Its standardized 100mg/ml dosage ensures reliable performance in professional B2B markets requiring precise hemostatic intervention.
